Pregled bibliografske jedinice broj: 340230
Tau protein expresion in frontoparietal cortex of experimental rat model of sporadic Alzheimer's disease.
Tau protein expresion in frontoparietal cortex of experimental rat model of sporadic Alzheimer's disease. // J Neural Transm / Riederer, Peter ; Gerlach, Manfred (ur.).
Beč: Springer, 2007. str. DP-03-09-DP-03-09 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 340230 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Tau protein expresion in frontoparietal cortex of experimental rat model of sporadic Alzheimer's disease.
Autori
Osmanovic, Jelena ; Salkovic-Petrisic, Melita ; Hoyer, Siegfried ; Riederer, Peter
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
J Neural Transm
/ Riederer, Peter ; Gerlach, Manfred - Beč : Springer, 2007, DP-03-09-DP-03-09
Skup
39th International Danube Symposium and the 1st International Congress on ADHD
Mjesto i datum
Würzburg, Njemačka, 02.06.2007. - 05.06.2007
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Streptozotocin rat model; Sporadic Alzheimer's Disease; Frontoparietal Cortex; Tau Protein
Sažetak
Objectives Neurofibrillar tangles are one of the major hallmarks of sporadic Alzheimer disease (sAD). They are associated with tau protein hyperphosphorylation which could happen due to imbalance in its phosphorylation/dephosphorylation status. Glycogen synthase kinase 3 which is involved in tau protein phosphorylation has bee found altered both in human sAD and in its experimental model, streptozotocin-intracerebroventricularly (STZ-icv) treated rats. In STZ-icv rat tau protein was measured in hippocampus only where increased total and phospho(p)-tau was found. Research was aimed to investigate the possible changes of tau protein in the frontoparietal cortex (FC) of STZ-icv rats one and three months following the treatment. Design and Methods Adult male Wistar rats were treated icv with a single STZ dose (1 mg/kg) while the controls received vehicle only. Cognitive functions were tested by Morrris Water Maze Swimming Test. Expression of total and p-tau protein was measured by SDS-PAGE/Western blot. Data were analysed by Mann-Whitney U test (p<0.05). Results Deficits in learning and memory functions were found both after 1 and 3 months following the STZ icv treatments (p<0.05). Decreased levels of total tau (74, 9%) and p-tau (49, 65%) (p<0.05) were found in FC after one month while three months after the treatment both tau values were comparable to the control ones. Conclusion Results suggest that STZ-icv induced changes of tau protein in FC are time dependent and regarding the increased tau phosphorylation reported in STZ-icv rat hippocampus they also seem to be brain-region dependent. Since changes found in human sAD refer mostly to the advanced stage of the disease while early changes are mystery. The possibility of similar tau protein alterations in human FC at the beginning of sAD could not be excluded. Supported by Croatian MZOS (108-1080003-0020) and DAAD.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
108-1080003-0020 - Mozak, eksperimentalni i cerebralni dijabetes i kognitivni i drugi poremećaji (Šalković-Petrišić, Melita, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE